Cargando…

Analysis of Sorafenib Outcome: Focusing on the Clinical Course in Patients with Hepatocellular Carcinoma

BACKGROUND: Treatment outcomes of sorafenib therapy may greatly vary depending not only on tumor spread but also on past clinical processes prior to sorafenib therapy and timing of sorafenib administration in the past clinical course of hepatocellular carcinoma (HCC). We evaluated the efficacy of so...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ogasawara, Sadahisa, Chiba, Tetsuhiro, Ooka, Yoshihiko, Suzuki, Eiichiro, Inoue, Masanori, Wakamatsu, Toru, Tawada, Akinobu, Yokosuka, Osamu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990272/ https://www.ncbi.nlm.nih.gov/pubmed/27537374 http://dx.doi.org/10.1371/journal.pone.0161303

Ejemplares similares

Impact of Radiofrequency Ablation-Induced Glisson’s Capsule-Associated Complications in Patients with Hepatocellular Carcinoma
por: Wakamatsu, Toru, et al.
Publicado: (2017)

Fatal Diaphragmatic Hernia following Radiofrequency Ablation for Hepatocellular Carcinoma: A Case Report and Literature Review
por: Saito, Tomoko, et al.
Publicado: (2015)

Partial Splenic Embolization with Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma Accompanied by Thrombocytopenia
por: Ooka, Yoshihiko, et al.
Publicado: (2014)

Incidental tumor necrosis caused by the interventional alteration of hepatic arterial flow in patients with advanced hepatocellular carcinoma
por: Suzuki, Eiichiro, et al.
Publicado: (2014)

Henoch-Schönlein Purpura Complicated by Hepatocellular Carcinoma
por: Akizue, Naoki, et al.
Publicado: (2017)

Successful Treatment of Hepatocellular Carcinoma Complicated by Fanconi Anemia
por: Takahashi, Koji, et al.
Publicado: (2017)

A Prognostic Score for Patients with Intermediate-Stage Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
por: Ogasawara, Sadahisa, et al.
Publicado: (2015)

Successful Resection of Intracranial Metastasis of Hepatocellular Carcinoma
por: Okimoto, Kenichiro, et al.
Publicado: (2013)

Successful Interventional Treatment for Arterioportal Fistula Caused by Radiofrequency Ablation for Hepatocellular Carcinoma
por: Kanogawa, Naoya, et al.
Publicado: (2014)

Simultaneous Resection of Disseminated Hepatocellular Carcinoma and Colon Cancer
por: Haga, Yuki, et al.
Publicado: (2013)

Effect of Previous Interferon-based Therapy on Recurrence after Curative Treatment of Hepatitis C Virus-related Hepatocellular Carcinoma
por: Saito, Tomoko, et al.
Publicado: (2014)

Prognostic Significance of Concurrent Hypovascular and Hypervascular Nodules in Patients with Hepatocellular Carcinoma
por: Ogasawara, Sadahisa, et al.
Publicado: (2016)

Transarterial chemoembolization as a substitute to radiofrequency ablation for treating Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma
por: Ishikawa, Kentaro, et al.
Publicado: (2018)

Intracranial Metastasis in a Patient with Hepatocellular Carcinoma and Gastric Cancer
por: Tawada, Akinobu, et al.
Publicado: (2014)

Metformin, a Diabetes Drug, Eliminates Tumor-Initiating Hepatocellular Carcinoma Cells
por: Saito, Tomoko, et al.
Publicado: (2013)

Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma
por: Yokoyama, Masayuki, et al.
Publicado: (2017)

Disulfiram Eradicates Tumor-Initiating Hepatocellular Carcinoma Cells in ROS-p38 MAPK Pathway-Dependent and -Independent Manners
por: Chiba, Tetsuhiro, et al.
Publicado: (2014)

Propofol versus midazolam for sedation during radiofrequency ablation in patients with hepatocellular carcinoma
por: Kanogawa, Naoya, et al.
Publicado: (2020)

Real-World Experiences with the Combination Treatment of Ledipasvir plus Sofosbuvir for 12 Weeks in HCV Genotype 1-Infected Japanese Patients: Achievement of a Sustained Virological Response in Previous Users of Peginterferon plus Ribavirin with HCV NS3/4A Inhibitors
por: Kanda, Tatsuo, et al.
Publicado: (2017)

Left gastric vein-based noninvasive test for esophageal varices: a same-day comparison of portal hemodynamic assessment with endoscopic appearance
por: Maruyama, Hitoshi, et al.
Publicado: (2018)

Acute Liver Failure in an Antimitochondrial Antibody-Positive 63-Year-Old Man
por: Wakamatsu, Toru, et al.
Publicado: (2012)

Clinical outcomes of endoscopic ultrasound-guided ethanol injection for hepatocellular carcinoma in the caudate lobe
por: Nakaji, So, et al.
Publicado: (2016)

Compensating effect of minor portal hypertension on the muscle mass loss-related poor prognosis in cirrhosis
por: Maruyama, Hitoshi, et al.
Publicado: (2017)

Switching to systemic therapy after locoregional treatment failure: Definition and best timing
por: Ogasawara, Sadahisa, et al.
Publicado: (2020)

Incidence and hemodynamic feature of risky esophageal varices with lower hepatic venous pressure gradient
por: Maruyama, Hitoshi, et al.
Publicado: (2019)

Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma
por: Maeda, Takahiro, et al.
Publicado: (2019)

Impact of skeletal muscle volume on patients with BCLC stage‐B hepatocellular carcinoma undergoing sorafenib therapy
por: Saeki, Issei, et al.
Publicado: (2023)

Skeletal Muscle Volume Is an Independent Predictor of Survival after Sorafenib Treatment Failure for Hepatocellular Carcinoma
por: Saeki, Issei, et al.
Publicado: (2021)

Treatment of Real-World HCV Genotype 2-Infected Japanese Patients with Sofosbuvir plus Ribavirin
por: Kanda, Tatsuo, et al.
Publicado: (2017)

The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma
por: Kanzaki, Hiroaki, et al.
Publicado: (2021)

Exploring microsatellite instability in patients with advanced hepatocellular carcinoma and its tumor microenvironment
por: Mukai, Shohei, et al.
Publicado: (2021)

The efficacy of contrast-enhanced computed tomography on the management of gastroesophageal varices in patients with hepatocellular carcinoma
por: Kondo, Takayuki, et al.
Publicado: (2022)

Impact of acute decompensation on the prognosis of patients with hepatocellular carcinoma
por: Kondo, Takayuki, et al.
Publicado: (2022)

EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma
por: Kusakabe, Yuko, et al.
Publicado: (2021)

Sustained Virologic Response at 24 Weeks after the End of Treatment Is a Better Predictor for Treatment Outcome in Real-World HCV-Infected Patients Treated by HCV NS3/4A Protease Inhibitors with Peginterferon plus Ribavirin
por: Kanda, Tatsuo, et al.
Publicado: (2016)

Natural history of large regenerative nodules and dysplastic nodules in liver cirrhosis: 28-year follow-up study
por: Sato, Tsunenobu, et al.
Publicado: (2015)

Genome-Wide Mapping of Bivalent Histone Modifications in Hepatic Stem/Progenitor Cells
por: Kanayama, Kengo, et al.
Publicado: (2019)

Serum Angiopoietin 2 acts as a diagnostic and prognostic biomarker in hepatocellular carcinoma
por: Ao, Junjie, et al.
Publicado: (2021)

Successful retreatment with grazoprevir and elbasvir for patients infected with hepatitis C virus genotype 1b, who discontinued prior treatment with NS5A inhibitor-including regimens due to adverse events
por: Kanda, Tatsuo, et al.
Publicado: (2018)

Association of IFNL3 Genotype with Hepatic Steatosis in Chronic Hepatitis C Patients Treated with Peginterferon and Ribavirin Combination Therapy
por: Nakamoto, Shingo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_abiiclikoddv2dgl1lqjlrm73b